Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review

被引:3
作者
Shehata, Islam [1 ]
Hashim, Ahmed [2 ]
Elsaeidy, Ahmed [3 ]
Nair, Anagha [4 ]
Urits, Ivan [5 ]
Viswanath, Omar [5 ]
Kaye, Alan [5 ]
Habib, Marian [6 ]
机构
[1] Ain Shams Univ, Anesthesiol, Cairo, Egypt
[2] Ain Shams Univ, Cairo, Egypt
[3] Benha Univ, Banha, Egypt
[4] Lady Hardinge Med Coll & Hosp, Cairo, Egypt
[5] Louisiana State Univ, Hlth Sci Ctr, Baton Rouge, LA 70803 USA
[6] Hurghada Gen Hosp, Dept Cardiol, Hurghada, Egypt
关键词
Cannabinoids; chronic pain; herbal cannabis; `hemp' products; pharmaceutical-grade regulated cannabinoid-based medical products; MARIJUANA USE; DOUBLE-BLIND; CANNABIDIOL; ACTIVATION; RECEPTOR; RISK; DISEASE; CANCER; COMPLICATIONS; METAANALYSIS;
D O I
10.52965/001c.35848
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
For decades, chronic pain was managed with an almost conventional approach of using a wide range of analgesic spectrum, surgical approaches and complex interventional pain techniques to modulate or even interrupt pain pathways. These different approaches carry many pharmacological hazards together with the lack of efficacy and safety of many interventional and surgical management techniques for chronic pain have mandated searching for other effective therapies including alternative treatments. Cannabinoids are naturally occurring substances that are derived from Cannabis sativa L. The usage of cannabinoids and their related synthetic chemical compounds has emerged as a choice in the management of different chronic pain conditions is being evaluated, however, the efficacy is still not consistently established. In the present investigation, therefore, we discuss the different aspects related to cannabinoids and their implications in the management of chronic pain conditions. This review will also discuss the safety profile of the cannabinoids together with the legal considerations that hinder their use in different countries.
引用
收藏
页数:19
相关论文
共 127 条
[1]   What are the psychological effects of using synthetic cannabinoids? A systematic review [J].
Akram, Hina ;
Mokrysz, Claire ;
Curran, H. Valerie .
JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (03) :271-283
[2]   Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial [J].
Allsop, David J. ;
Copeland, Jan ;
Lintzeris, Nicholas ;
Dunlop, Adrian J. ;
Montebello, Mark ;
Sadler, Craig ;
Rivas, Gonzalo R. ;
Holland, Rohan M. ;
Muhleisen, Peter ;
Norberg, Melissa M. ;
Booth, Jessica ;
McGregor, Iain S. .
JAMA PSYCHIATRY, 2014, 71 (03) :281-291
[3]   The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial [J].
Almog, Shlomo ;
Aharon-Peretz, Judith ;
Vulfsons, Simon ;
Ogintz, Miri ;
Abalia, Hadas ;
Lupo, Tal ;
Hayon, Yael ;
Eisenberg, Elon .
EUROPEAN JOURNAL OF PAIN, 2020, 24 (08) :1505-1516
[4]   Antioxidative and Anti-Inflammatory Properties of Cannabidiol [J].
Atalay, Sinemyiz ;
Jarocka-Karpowicz, Iwona ;
Skrzydlewska, Elzbieta .
ANTIOXIDANTS, 2020, 9 (01)
[5]   International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis [J].
Bahji, Anees ;
Stephenson, Callum .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (17)
[6]   The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors [J].
Bakas, T. ;
van Nieuwenhuijzen, P. S. ;
Devenish, S. O. ;
McGregor, I. S. ;
Arnold, J. C. ;
Chebib, M. .
PHARMACOLOGICAL RESEARCH, 2017, 119 :358-370
[7]   An Overview of Pharmacologic Management of Chronic Pain [J].
Beal, Benjamin R. ;
Wallace, Mark S. .
MEDICAL CLINICS OF NORTH AMERICA, 2016, 100 (01) :67-+
[8]   Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers [J].
Bedi, Gillinder ;
Cooper, Ziva D. ;
Haney, Margaret .
ADDICTION BIOLOGY, 2013, 18 (05) :872-881
[9]  
Ben Amar M, 2007, J PSYCHOACTIVE DRUGS, V39, P131
[10]  
Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105